|1.||Hall, Jennifer B: 1 article (02/2012)|
|2.||Rodriguez, Jamie C: 1 article (02/2012)|
|3.||Potter, Timothy M: 1 article (02/2012)|
|4.||McNeil, Scott E: 1 article (02/2012)|
|5.||Patri, Anil K: 1 article (02/2012)|
|6.||Dobrovolskaia, Marina A: 1 article (02/2012)|
|7.||Cybulsky, Irene J: 1 article (08/2007)|
|8.||Heggtveit, H Alexander: 1 article (08/2007)|
|9.||Morris, Andrew M: 1 article (08/2007)|
|10.||Walker, Irwin R: 1 article (08/2007)|
06/15/2001 - "In acute myocardial infarction (AMI), monocyte procoagulant activity is increased and may contribute to the risk for recurrence and other thrombotic events. "
10/15/1998 - "This study sought to investigate monocyte procoagulant activity and Mac-1 expression after successful percutaneous transluminal coronary angioplasty (PTCA) in acute myocardial infarction (AMI). "
01/01/1995 - "Unstable angina and myocardial infarction are associated with enhanced mononuclear cell procoagulant activity. "
01/22/2002 - "In acute myocardial infarction (AMI), surface-bound tissue factor pathway inhibitor-1 (TFPI-1) inhibits an increased monocyte procoagulant activity. "
06/15/2001 - "Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1."
|3.||Shwartzman Phenomenon (Shwartzman Reaction)
09/01/1978 - "Procoagulant activity of peritoneal leukocytes from rabbits given cortisone acetate, endotoxin, and both materials was measured in studies designed to test the hypothesis that cortisone acetate prepares rabbits for the generalized Shwartzman reaction by enhancing leukocyte procoagulant activity. "
01/01/1988 - "Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients."
08/01/1987 - "An assessment of monocyte procoagulant activity in patients with solid tumors."
02/01/2012 - "Thrombogenicity associated with the induction of leukocyte procoagulant activity (PCA) is a common complication in sepsis and cancer. "
12/01/1990 - "Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration."
|3.||Thromboplastin (Tissue Factor)
|6.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|8.||Interleukin-10 (Interleukin 10)
|9.||Lupus Coagulation Inhibitor (Lupus Anticoagulant)
|1.||Coronary Balloon Angioplasty (Percutaneous Transluminal Coronary Angioplasty)